SARS-CoV-2 viral dynamics and population pharmacokinetics of favipiravir in combination with lopinavir-ritonavir in patients with COVID-19

被引：0
|
作者：
Agyeman, Akosua A. [1 ]
Brown, Li-An K. [2 ]
Guerra-Assuncao, Jose A.
Breuer, Judy [1 ,3 ]
Lowe, David M. [2 ,4 ]
Standing, Joseph F. [1 ,5 ]
机构：
[1] UCL, Great Ormond St Inst Child Hlth, Infect Immun & Inflammat Res & Teaching Dept, London, England
[2] UCL, Inst Immun & Transplantat, Royal Free Campus, London, England
[3] Great Ormond St Hosp Sick Children, Dept Microbiol, London, England
[4] Royal Free London NHS Fdn Trust, Dept Clin Immunol, London, England
[5] Great Ormond St Hosp Sick Children, Dept Pharm, London, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0348
引用
收藏
页码：291 / 294
页数：4
相关论文
共 50 条
  • [31] Viral dynamics of SARS-CoV-2 across a spectrum of disease severity in COVID-19
    Lui, Grace
    Ling, Lowell
    Lai, Christopher K. C.
    Tso, Eugene Y. K.
    Fung, Kitty S. C.
    Chan, Veronica
    Ho, Tracy Hy
    Luk, Fion
    Chen, Zigui
    Ng, Joyce K. C.
    Chow, Kai-Ming
    Cheng, Peter K. C.
    Chan, Rickjason C. W.
    Tsang, Dominic N. C.
    Gomersall, Charles D.
    Hui, David S. C.
    Chan, Paul K. S.
    JOURNAL OF INFECTION, 2020, 81 (02) : 324 - 327
  • [32] Safety profile of the lopinavir/ritonavir combination before and during the SARS-CoV-2 pandemic
    Lory, Pauline
    Combret, Sandrine
    Michot, Joelle
    Veyrac, Gwenaelle
    Chouchana, Laurent
    Grandvuillemin, Aurelie
    THERAPIE, 2023, 78 (04): : 419 - 425
  • [33] Impact of Prolonged SARS-CoV-2 Viral Shedding on COVID-19 Disease Outcome and Viral Dynamics
    Sanyaolu, Adekunle
    Marinkovic, Aleksandra
    Prakash, Stephanie
    Balendra, Vyshnavy
    Hamdy, Kareem
    Haider, Nafees
    Abbasi, Abu Fahad
    Hosein, Zaheeda
    Younis, Kokab
    Smith, Stella
    Badaru, Olanrewaju
    Izurieta, Ricardo
    INDIAN JOURNAL OF MICROBIOLOGY, 2024, 64 (04) : 1416 - 1424
  • [34] Favipiravir and the Need for Early Ambulatory Treatment of SARS-CoV-2 Infection (COVID-19)
    McCullough, Peter A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (12)
  • [35] Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19
    Muralidharan, Nisha
    Sakthivel, R.
    Velmurugan, D.
    Gromiha, M. Michael
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (07): : 2673 - 2678
  • [36] HEPATIC EFFECTS OF COVID-19 TREATMENT WITH INTERFERON-ALPHA AND LOPINAVIR-RITONAVIR
    Jeyarajan, Andre
    Shao, Tuo
    Tong, Yu
    Chen, Dong
    Chung, Raymond T.
    HEPATOLOGY, 2020, 72 : 274A - 275A
  • [37] Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
    Qomara, Windi Fresha
    Primanissa, Delya Nur
    Amalia, Salma Hasni
    Purwadi, Febby, V
    Zakiyah, Neily
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 8557 - 8571
  • [38] SARS-CoV-2 and COVID-19
    Sheng, Wang-Huei
    Ko, Wen-Chien
    Huang, Yhu-Chering
    Hsueh, Po-Ren
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (03) : 363 - 364
  • [39] Presumed SARS-CoV-2 Viral Particles in the Human Retina of Patients With COVID-19
    Araujo-Silva, Carlla A.
    Marcos, Allexya A. A.
    Marinho, Paula M.
    Branco, Ana M. C.
    Roque, Alexandre
    Romano, Andre C.
    Matuoka, Mateus L.
    Farah, Michel
    Burnier, Miguel
    Moraes, Nara F.
    Tierno, Paulo F. G. M. M.
    Schor, Paulo
    Sakamoto, Victoria
    Nascimento, Heloisa
    de Sousa, Wanderley
    Belfort, Rubens, Jr.
    JAMA OPHTHALMOLOGY, 2021, 139 (09) : 1015 - 1021
  • [40] Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)
    Schoergenhofer, Christian
    Jilma, Bernd
    Stimpfl, Thomas
    Karolyi, Mario
    Zoufaly, Alexander
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (08) : 670 - +
12345